There is no cure or specific antiviral treatment for Epstein-Barr virus (EBV). The standard approach is managing symptoms while your immune system clears the active infection, which typically takes two to four weeks for the worst symptoms and up to several months for lingering fatigue. Most people recover fully with rest, fluids, and over-the-counter pain relief, but certain complications require medical attention.
Why Antivirals Don’t Work for EBV
You might expect that an antiviral drug would be the obvious treatment, but the evidence doesn’t support it. A Cochrane review analyzed seven randomized trials covering 333 patients treated with antiviral medications. The results were underwhelming: out of 12 measured outcomes, only two showed any improvement. Treated patients recovered about five days faster by physician assessment and had swollen lymph nodes for about nine fewer days, but there was no meaningful difference in fever duration, sore throat severity, or overall well-being.
Perhaps most telling, antivirals did suppress the virus while patients were actively taking the medication, but the effect disappeared as soon as treatment stopped. The review concluded that the effectiveness of antivirals for acute EBV infection is “uncertain” based on very low quality evidence. This is why doctors don’t prescribe them for standard cases.
Managing Symptoms at Home
Since EBV treatment is about comfort and recovery, here’s what actually helps:
- Pain and fever relief. Standard over-the-counter medications for pain and fever are the CDC’s primary recommendation. These address the sore throat, headaches, body aches, and fever that make the first one to two weeks miserable.
- Rest. Your body is fighting a significant infection. Fatigue during EBV isn’t ordinary tiredness; it reflects genuine immune system demand. Pushing through it tends to prolong recovery.
- Hydration. Fever and reduced appetite can lead to dehydration quickly, especially when swallowing is painful. Cold fluids, ice pops, and soft foods help maintain intake when your throat is at its worst.
- Nutritional support. Vitamin C plays a role in immune cell health and energy metabolism, and viral infections can deplete your body’s stores. Vitamin D also modulates both the innate and adaptive immune systems. Eating nutrient-dense foods or supplementing these vitamins during recovery supports your body’s ability to fight the infection, though neither is a cure on its own.
Protecting Your Spleen
EBV commonly causes the spleen to enlarge, and a ruptured spleen is the most dangerous complication of infectious mononucleosis. The majority of spleen injuries occur within the first 21 days of illness and become exceedingly rare after 28 days. The spleen typically reaches its peak size within the first two weeks, though swelling can extend to three and a half weeks.
This timeline drives the standard recommendation: rest for at least three weeks, then begin light activity. Contact sports, heavy lifting, and anything involving potential abdominal impact should wait until well past that window. Ultrasound can check spleen size, but normal spleen measurements vary so much between individuals that imaging alone isn’t a reliable green light for returning to full activity. Your doctor will factor in your symptoms, how long it’s been since they started, and imaging results together.
When Complications Need More Aggressive Treatment
In a small number of cases, EBV causes severe swelling of the tonsils and surrounding tissue, enough to partially or fully block the airway. This is the primary situation where corticosteroids (strong anti-inflammatory medications) become appropriate. Corticosteroids are reserved for impending airway obstruction, autoimmune complications like the body destroying its own red blood cells or platelets, and other severe circumstances. They are not recommended for the typical sore throat, fatigue, or swollen glands of uncomplicated mono.
If corticosteroids fail to open the airway, surgical removal of the tonsils or other procedures may be necessary, though this is rare. The key point: if you’re having difficulty breathing, producing a high-pitched sound when inhaling, or can’t swallow your own saliva, that’s a medical emergency.
The Recovery Timeline
EBV recovery doesn’t follow a clean, linear path. The acute phase, with fever, severe sore throat, and swollen lymph nodes, generally lasts one to two weeks. Most people feel well enough to return to normal activities within three to four weeks, though you may still tire more easily than usual.
Fatigue is the symptom that lingers longest and frustrates people the most. It can persist for weeks or, in some cases, months after all other symptoms have resolved. There’s no way to speed this up reliably. Gradual increases in activity, consistent sleep, and good nutrition are the most practical strategies. Trying to power through prolonged fatigue often backfires, leading to setbacks that extend recovery further.
EBV and Chronic Fatigue
Chronic fatigue syndrome (ME/CFS) was originally described in reference to post-EBV fatigue, and the connection between the two has been studied extensively. Research has found elevated antibodies against EBV proteins, signs of defective EBV-specific immune responses, and evidence of EBV reactivation in a subset of ME/CFS patients. However, these findings haven’t been consistently replicated, and most studies show no increase in EBV viral load in ME/CFS patients overall.
The current scientific position is that EBV is a risk factor for ME/CFS in some people, but the association is not established as causal. If your fatigue persists beyond six months and comes with other hallmarks like post-exertional malaise (feeling significantly worse after physical or mental effort), cognitive difficulty, and unrefreshing sleep, it’s worth being evaluated for ME/CFS specifically rather than assuming it’s just slow EBV recovery.
Chronic Active EBV
Chronic active Epstein-Barr virus disease (CAEBV) is a rare and serious condition distinct from ordinary mono. In CAEBV, the virus persists in an active state and causes ongoing organ damage, recurring fevers, and progressive immune dysfunction. No standard treatment protocol exists. The only known curative treatment is a stem cell transplant, with chemotherapy sometimes used beforehand to control disease activity. This condition is uncommon and primarily managed by specialists.
Getting an Accurate Diagnosis
If you’re treating EBV symptoms, it helps to know whether EBV is actually what you have. The Monospot test, still widely used, is no longer recommended by the CDC for general use. It detects antibodies that can be caused by conditions other than mono, producing both false positives and false negatives. It’s particularly unreliable in children, who often don’t produce the antibodies the test looks for.
EBV-specific antibody tests are more accurate and can distinguish between a new infection, a past infection, and a reactivation. These are typically ordered when symptoms don’t follow the classic mono pattern or when another EBV-related condition is suspected. Even these tests have limitations: about 20% of healthy people carry certain EBV antibodies for years after infection, which can complicate interpretation.
No Vaccine Yet
No preventive or therapeutic EBV vaccine is currently available. The most advanced candidates target a protein called gp350, the most abundant molecule on the virus’s outer surface, and some have reached early clinical trials. Newer approaches using mRNA and nanoparticle technology remain in preclinical stages. Given that EBV infects roughly 95% of adults worldwide and is linked to several cancers and autoimmune conditions, vaccine development is an active area of research, but nothing is close to market.